Health
J&J vaccine adds to COVID-19 armoury, includes South African variant – Reuters
Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants, giving…
(Reuters) – Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants, giving health officials another weapon to tackle the pandemic.
In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 varied from 72% in the United States, to 66% in Latin America and just 57% in South Africa, from where a worrying variant has spread.
The data showed that the vaccines…
-
Noosa News23 hours agoFervor Wines label started during pandemic keeps father and son close
-
General19 hours agoAFLW Sunday: Chloe Molloy kicks wonder goal as Zippy Fish stars for Swans
-
General19 hours agoLambie, hypocrisy, and the misinformation & disinformation bill
-
Noosa News23 hours agoInfluencer’s croc-wrangling videos spark government investigation